{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:45:57Z","timestamp":1791773157892,"version":"4.3.4"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.intimp.2025.115304","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T07:46:09Z","timestamp":1754379969000},"page":"115304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Hesperidin ameliorates hepatocyte cell cycle disruption, apoptosis, and necroptosis in mice with nonalcoholic fatty liver disease via the VEGFA-PI3K\/AKT pathway"],"prefix":"10.1016","volume":"163","author":[{"given":"Aqun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2025.115304_bb0005","first-page":"691","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.intimp.2025.115304_bb0010","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1038\/s41401-022-00907-5","article-title":"Hepatocyte-derived VEGFA accelerates the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma via activating hepatic stellate cells","volume":"43","author":"Shen","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"issue":"7","key":"10.1016\/j.intimp.2025.115304_bb0015","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2025.115304_bb0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12983-019-0341-x","article-title":"Characterizing the composition, metabolism and physiological functions of the fatty liver in Rana omeimontis tadpoles","volume":"16","author":"Zhu","year":"2019","journal-title":"Front. Zool."},{"issue":"5","key":"10.1016\/j.intimp.2025.115304_bb0025","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology (Baltimore, Md.)"},{"issue":"3","key":"10.1016\/j.intimp.2025.115304_bb0030","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/hep.27839","article-title":"Hepatic lipid droplet biology: getting to the root of fatty liver, hepatology","volume":"vol. 62","author":"Mashek","year":"2015","journal-title":"Baltimore, Md"},{"issue":"3","key":"10.1016\/j.intimp.2025.115304_bb0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41580-018-0085-z","article-title":"Dynamics and functions of lipid droplets","volume":"20","author":"Olzmann","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1 Suppl","key":"10.1016\/j.intimp.2025.115304_bb0040","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115304_bb0045","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"issue":"7503","key":"10.1016\/j.intimp.2025.115304_bb0050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/nature13478","article-title":"The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes","volume":"510","author":"Perry","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2025.115304_bb0055","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41420-024-02168-z","article-title":"Targeting cell death in NAFLD: mechanisms and targeted therapies","volume":"10","author":"Xu","year":"2024","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.intimp.2025.115304_bb0060","first-page":"391","article-title":"Angiogenesis--an update","volume":"2","author":"Roguin","year":"2005","journal-title":"Pediatric Endocrinol. Rev.: PER"},{"key":"10.1016\/j.intimp.2025.115304_bb0065","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev.pathol.2.010506.134925","article-title":"VEGF-A and the induction of pathological angiogenesis","volume":"2","author":"Nagy","year":"2007","journal-title":"Annu. Rev. Pathol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115304_bb0070","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrd.2015.17","article-title":"Ten years of anti-vascular endothelial growth factor therapy","volume":"15","author":"Ferrara","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.intimp.2025.115304_bb0075","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1242\/dev.126.6.1149","article-title":"VEGF is required for growth and survival in neonatal mice","volume":"126","author":"Gerber","year":"1999","journal-title":"Development"},{"issue":"15","key":"10.1016\/j.intimp.2025.115304_bb0080","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.1073\/pnas.1200447109","article-title":"Dichotomous effects of VEGF-A on adipose tissue dysfunction","volume":"109","author":"Sun","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.intimp.2025.115304_bb0085","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.2337\/db13-1665","article-title":"Systemic VEGF-A neutralization ameliorates diet-induced metabolic dysfunction","volume":"63","author":"Wu","year":"2014","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.intimp.2025.115304_bb0090","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmet.2012.12.010","article-title":"Adipose vascular endothelial growth factor regulates metabolic homeostasis through angiogenesis","volume":"17","author":"Sung","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.intimp.2025.115304_bb0095","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.lfs.2014.12.030","article-title":"Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases","volume":"124","author":"Roohbakhsh","year":"2015","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.intimp.2025.115304_bb0100","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0031-9422(00)00235-1","article-title":"Advances in flavonoid research since 1992","volume":"55","author":"Harborne","year":"2000","journal-title":"Phytochemistry"},{"issue":"7","key":"10.1016\/j.intimp.2025.115304_bb0105","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1021\/np9904509","article-title":"Flavonoids as antioxidants","volume":"63","author":"Pietta","year":"2000","journal-title":"J. Nat. Prod."},{"issue":"7","key":"10.1016\/j.intimp.2025.115304_bb0110","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1002\/ptr.8207","article-title":"7-Hydroxyflavone improves nonalcoholic fatty liver disease by acting on STK24","volume":"38","author":"Qi","year":"2024","journal-title":"Phytother. Res.: PTR"},{"issue":"1","key":"10.1016\/j.intimp.2025.115304_bb0115","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1039\/D3FO04348G","article-title":"The promotion of fatty acid \u03b2-oxidation by hesperidin via activating SIRT1\/PGC1\u03b1 to improve NAFLD induced by a high-fat diet","volume":"15","author":"Nie","year":"2024","journal-title":"Food Funct."},{"issue":"1","key":"10.1016\/j.intimp.2025.115304_bb0120","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41430-020-0679-3","article-title":"The efficacy of flaxseed and hesperidin on non-alcoholic fatty liver disease: an open-labeled randomized controlled trial","volume":"75","author":"Yari","year":"2021","journal-title":"Eur. J. Clin. Nutr."},{"issue":"8","key":"10.1016\/j.intimp.2025.115304_bb0125","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/ptr.6406","article-title":"Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: a randomized, placebo-controlled, double-blind clinical trial","volume":"33","author":"Cheraghpour","year":"2019","journal-title":"Phytother. Res.: PTR"},{"issue":"18","key":"10.1016\/j.intimp.2025.115304_bb0130","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1021\/acs.jafc.3c01099","article-title":"Gallotannin isolated from pericarp of water caltrop ameliorates high-fat diet-induced nonalcoholic fatty liver disease in mice","volume":"71","author":"L\u00fc","year":"2023","journal-title":"J. Agric. Food Chem."},{"issue":"11","key":"10.1016\/j.intimp.2025.115304_bb0135","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14852","article-title":"Does naringenin supplementation improve lipid profile, severity of hepatic steatosis and probability of liver fibrosis in overweight\/obese patients with NAFLD? A randomised, double-blind, placebo-controlled, clinical trial","volume":"75","author":"Namkhah","year":"2021","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.intimp.2025.115304_bb0140","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.2147\/DDDT.S227499","article-title":"Hesperidin: a therapeutic agent for obesity","volume":"13","author":"Xiong","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"issue":"12","key":"10.1016\/j.intimp.2025.115304_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/nu14122387","article-title":"Hesperidin: a review on extraction methods, stability and biological activities","volume":"14","author":"Pyrzynska","year":"2022","journal-title":"Nutrients"},{"issue":"13","key":"10.1016\/j.intimp.2025.115304_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28135152","article-title":"Hesperidin, a bioflavonoid in cancer therapy: a review for a mechanism of action through the modulation of cell signaling pathways","volume":"vol. 28","author":"Rahmani","year":"2023","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"50","key":"10.1016\/j.intimp.2025.115304_bb0155","doi-asserted-by":"crossref","first-page":"20105","DOI":"10.1021\/acs.jafc.3c06498","article-title":"Nobiletin ameliorates hepatic lipid deposition, oxidative stress, and inflammation by mechanisms that involve the Nrf2\/NF-\u03baB Axis in nonalcoholic fatty liver disease","volume":"71","author":"Fan","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.intimp.2025.115304_bb0160","article-title":"Systems pharmacology study of the anti-liver injury mechanism of Citri Reticulatae Pericarpium","volume":"12","author":"Wu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115304_bb0165","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115304_bb0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cld.2017.08.007","article-title":"Pathophysiology of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis","volume":"22","author":"Manne","year":"2018","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.intimp.2025.115304_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117379","article-title":"Vitexin alleviates lipid metabolism disorders and hepatic injury in obese mice through the PI3K\/AKT\/mTOR\/SREBP-1c pathway","volume":"287","author":"Liu","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"D1","key":"10.1016\/j.intimp.2025.115304_bb0180","doi-asserted-by":"crossref","first-page":"D1197","DOI":"10.1093\/nar\/gkaa1063","article-title":"HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine","volume":"49","author":"Fang","year":"2021","journal-title":"Nucleic Acids Res."},{"issue":"36","key":"10.1016\/j.intimp.2025.115304_bb0185","doi-asserted-by":"crossref","first-page":"15134","DOI":"10.1074\/jbc.M117.785238","article-title":"R213I mutation in release factor 2 (RF2) is one step forward for engineering an omnipotent release factor in bacteria Escherichia coli","volume":"292","author":"Korkmaz","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.intimp.2025.115304_bb0190","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13059-017-1215-1","article-title":"Multi-omics approaches to disease","volume":"18","author":"Hasin","year":"2017","journal-title":"Genome Biol."},{"key":"10.1016\/j.intimp.2025.115304_bb0195","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2020.599548","article-title":"Insights into Translatomics in the nervous system","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Genet."},{"issue":"6","key":"10.1016\/j.intimp.2025.115304_bb0200","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"issue":"(2\u20133","key":"10.1016\/j.intimp.2025.115304_bb0205","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1385\/IR:23:2-3:263","article-title":"VEGF as a mediator of tumor-associated immunodeficiency","volume":"23","author":"Ohm","year":"2001","journal-title":"Immunol. Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115304_bb0210","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.immuni.2013.07.005","article-title":"Deciphering and reversing tumor immune suppression","volume":"39","author":"Motz","year":"2013","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2025.115304_bb0215","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/s12967-023-04122-6","article-title":"The convergent application of metabolites from Avena sativa and gut microbiota to ameliorate non-alcoholic fatty liver disease: a network pharmacology study","volume":"21","author":"Oh","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.intimp.2025.115304_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111306","article-title":"Diosgenin attenuates nonalcoholic fatty liver disease through mTOR-mediated inhibition of lipid accumulation and inflammation","volume":"405","author":"Yin","year":"2025","journal-title":"Chem. Biol. Interact."},{"issue":"3","key":"10.1016\/j.intimp.2025.115304_bb0225","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1080\/21655979.2022.2037374","article-title":"Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verification","volume":"13","author":"Jiang","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.intimp.2025.115304_bb0230","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2384140","article-title":"Multiple mechanisms of Shenqi pill in treating nonalcoholic fatty liver disease based on network pharmacology and molecular docking","volume":"2022","author":"Tong","year":"2022","journal-title":"Evidence-Based Complementary Alternative Med.: eCAM"},{"issue":"3","key":"10.1016\/j.intimp.2025.115304_bb0235","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2022.12801","article-title":"Reducing VEGFB expression regulates the balance of glucose and lipid metabolism in mice via VEGFR1","volume":"26","author":"Luo","year":"2022","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2025.115304_bb0240","doi-asserted-by":"crossref","DOI":"10.3390\/nu14050954","article-title":"Mechanism of Astragalus membranaceus alleviating acquired hyperlipidemia induced by high-fat diet through regulating lipid metabolism","volume":"14","author":"Wang","year":"2022","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.intimp.2025.115304_bb0245","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jhep.2020.04.001","article-title":"Lytic cell death in metabolic liver disease","volume":"73","author":"Gautheron","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.intimp.2025.115304_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109199","article-title":"High fat diet-triggered non-alcoholic fatty liver disease: a review of proposed mechanisms","volume":"330","author":"Lian","year":"2020","journal-title":"Chem. Biol. Interact."},{"issue":"19","key":"10.1016\/j.intimp.2025.115304_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e38538","article-title":"Black rice bran extract exerts hepatoprotection via attenuating inflammation and apoptosis in obese-insulin-resistant rats","volume":"10","author":"Laorodphun","year":"2024","journal-title":"Heliyon"},{"issue":"7","key":"10.1016\/j.intimp.2025.115304_bb0260","doi-asserted-by":"crossref","first-page":"4205","DOI":"10.1039\/D2FO00298A","article-title":"Hesperidin protects against cisplatin-induced cardiotoxicity in mice by regulating the p62-Keap1-Nrf2 pathway","volume":"13","author":"Jia","year":"2022","journal-title":"Food Funct."},{"issue":"23","key":"10.1016\/j.intimp.2025.115304_bb0265","doi-asserted-by":"crossref","first-page":"13039","DOI":"10.1021\/acs.jafc.3c09132","article-title":"Elevated PINK1\/Parkin-dependent Mitophagy and boosted mitochondrial function mediate protection of HepG2 cells from excess palmitic acid by Hesperetin","volume":"72","author":"Li","year":"2024","journal-title":"J. Agric. Food Chem."},{"issue":"9","key":"10.1016\/j.intimp.2025.115304_bb0270","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41419-023-06161-9","article-title":"The oleic\/palmitic acid imbalance in exosomes isolated from NAFLD patients induces necroptosis of liver cells via the elongase-6\/RIP-1 pathway","volume":"14","author":"Scavo","year":"2023","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.intimp.2025.115304_bb0275","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302446","article-title":"Divergent roles of RIPK3 and MLKL in high-fat diet-induced obesity and MAFLD in mice","volume":"8","author":"Tye","year":"2025","journal-title":"Life Sci. Alliance"},{"issue":"1","key":"10.1016\/j.intimp.2025.115304_bb0280","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13020-021-00493-4","article-title":"Traditional herbal formula Wu-Mei-Wan alleviates TNBS-induced colitis in mice by inhibiting necroptosis through increasing RIPK3 O-GlcNAcylation","volume":"16","author":"Wu","year":"2021","journal-title":"Chin. Med."},{"issue":"3","key":"10.1016\/j.intimp.2025.115304_bb0285","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1053\/j.gastro.2020.05.056","article-title":"Agonist of RORA attenuates nonalcoholic fatty liver progression in mice via up-regulation of MicroRNA 122","volume":"159","author":"Chai","year":"2020","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.intimp.2025.115304_bb0290","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12072-020-10066-6","article-title":"Cell cycle regulation in NAFLD: when imbalanced metabolism limits cell division","volume":"14","author":"Caldez","year":"2020","journal-title":"Hepatol. Int."},{"issue":"2","key":"10.1016\/j.intimp.2025.115304_bb0295","first-page":"211","article-title":"Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs)","volume":"11","author":"Gra\u00f1a","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2025.115304_bb0300","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbrc.2023.09.038","article-title":"Cdh1 plays a protective role in nonalcoholic fatty liver disease by regulating PPAR\/PGC-1\u03b1 signaling pathway","volume":"681","author":"Chen","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2025.115304_bb0305","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1172\/JCI73957","article-title":"Oxidative stress promotes pathologic polyploidization in nonalcoholic fatty liver disease","volume":"125","author":"Gentric","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.intimp.2025.115304_bb0310","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1002\/ptr.8013","article-title":"Galangin: a food-derived flavonoid with therapeutic potential against a wide spectrum of diseases","volume":"37","author":"Wang","year":"2023","journal-title":"Phytother. Res.: PTR"},{"key":"10.1016\/j.intimp.2025.115304_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156671","article-title":"Ebselen improves lipid metabolism by activating PI3K\/Akt and inhibiting TLR4\/JNK signaling pathway to alleviate nonalcoholic fatty liver","volume":"181","author":"Pan","year":"2024","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.intimp.2025.115304_bb0320","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1039\/D0FO02736G","article-title":"Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K\/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD","volume":"12","author":"Li","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.intimp.2025.115304_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2024.116854","article-title":"Hesperetin alleviates aflatoxin B1 induced liver toxicity in mice: modulating lipid peroxidation and ferritin autophagy","volume":"284","author":"Song","year":"2024","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"1","key":"10.1016\/j.intimp.2025.115304_bb0330","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41420-021-00759-8","article-title":"CircMYOF triggers progression and facilitates glycolysis via the VEGFA\/PI3K\/AKT axis by absorbing miR-4739 in pancreatic ductal adenocarcinoma","volume":"7","author":"Zheng","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2025.115304_bb0335","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3389\/fphar.2019.00886","article-title":"Calcium Dobesilate restores autophagy by inhibiting the VEGF\/PI3K\/AKT\/mTOR signaling pathway","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"15","key":"10.1016\/j.intimp.2025.115304_bb0340","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.7150\/ijbs.103225","article-title":"Inhibition of miR-4763-3p expression activates the PI3K\/mTOR\/Bcl2 autophagy signaling pathway to ameliorate cognitive decline","volume":"20","author":"Qi","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2025.115304_bb0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.108582","article-title":"Evidence of promoting effects of 6:2 cl-PFESA on hepatocellular carcinoma proliferation in humans: An ideal alternative for PFOS in terms of environmental health?","volume":"186","author":"Hong","year":"2024","journal-title":"Environ. Int."},{"issue":"6","key":"10.1016\/j.intimp.2025.115304_bb0350","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1021\/acs.molpharmaceut.2c00887","article-title":"Progesterone-cationic lipid conjugate-based self-aggregates for Cancer cell-selective uptake through macropinocytosis and the antitumour effect","volume":"20","author":"Mondal","year":"2023","journal-title":"Mol. Pharm."},{"issue":"6","key":"10.1016\/j.intimp.2025.115304_bb0355","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.apsb.2021.12.023","article-title":"Gentiopicroside targets PAQR3 to activate the PI3K\/AKT signaling pathway and ameliorate disordered glucose and lipid metabolism","volume":"12","author":"Xiao","year":"2022","journal-title":"Acta Pharm. Sin. B"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925012950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925012950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:16:33Z","timestamp":1757913393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925012950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":71,"alternative-id":["S1567576925012950"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115304","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hesperidin ameliorates hepatocyte cell cycle disruption, apoptosis, and necroptosis in mice with nonalcoholic fatty liver disease via the VEGFA-PI3K\/AKT pathway","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115304"}}